Advertisement
Research Article| Volume 7, ISSUE 3, P545-550, September 1987

Download started.

Ok

Lithium Monitoring

  • Christopher S. Frings
    Correspondence
    Chris Frings Consulting Services, 633 Win wood Drive, Birmingham, Alabama 35226
    Affiliations
    Senior Vice President, Technical Services, and Director, Clinical Chemistry and Toxicology, Medical Laboratory Associates

    Clinical Professor, Pathology Department, School of Medicine, and Clinical Professor, School of Community and Allied Health, University of Alabama, Birmingham, Alabama
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30730-3
Lithium Monitoring
Previous ArticleFlucytosine (5-fluorocytosine)
Next ArticleMonitoring Cyclic Antidepressants
      This paper is only available as a PDF. To read, Please Download here.
      Owing to a narrow therapeutic range and significant toxicides, lithium must be used with caution in the treatment of bipolar-effective illness. Blood samples for lithium monitoring should be obtained 12 hours after the evening dose. Clinicians should be aware of drug-drug interactions and make appropriate adjustments in lithium dosage whenever a change in regimen occurs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Amidsen A.
        Monitoring of lithium treatment through determination of lithium concentration.
        Dan Med Bull. 1975; 22: 277-291
        • Amidsen A.
        Serum level monitoring and clinical pharmacokinetics of lithium.
        Clin Pharmacokinet. 1977; 2: 73-92
      3. Azidothymidine for AIDS.
        Med Lett Drugs Ther. Oct 24, 1986; 28: 107-110
        • Bassuk E.
        • et al.
        The Practitioner’s Guide to Psychoactive Drugs. Plenum Medical Book Company, New York1977
        • Beck P.
        • et al.
        Quantitative rating of manic states.
        Acta Psychiatr Scand. 1975; 52: 1-6
        • Corcoran A.
        • et al.
        Lithium poisoning from the use of salt substitute.
        JAMA. 1949; 139: 685-688
        • Gold D.
        • et al.
        Lithium “failure”: Nonresponders versus subtherapeutic levels.
        Hosp Formul. 1982; 17: 561-567
        • Hansen H.
        • et al.
        Lithium intoxication.
        Q J Med. 1978; 47: 123-144
        • Jaffe C.
        First degree atrioventricular block during lithium carbonate treatment.
        Am J Psychiatry. 1977; 134: 88-89

      10. Jefferson J, et al: Lithium Encyclopedia for Clinical Practice, 1983

        • Lydiard R.
        • et al.
        Hazards and adverse effects of lithium.
        Annu Rev Med. 1982; 33: 327-344
        • Needham T.
        • et al.
        Bioavailability and dissolution parameters of seven lithium carbonate products.
        J Pharm Sci. 1979; 68: 952-954
        • Pesin S.
        • et al.
        Therapeutic lithium levels after divided-dose loading with slow release lithium carbonate.
        Drug Intell Clin Pharm. 1982; 16: 479
        • Platman S.
        • et al.
        Absorption and excretion of lithium in manic depressive disease.
        Dis Nerv Sys. 1968; 29: 733-738
        • Prein R.
        • et al.
        Relationship between dosage and response to lithium prophylaxis in recurrent depression.
        Am J Psychiatry. 1976; 133: 567-570
        • Prein R.
        • et al.
        Relationship between serum lithium level and clinical response to acute mania treated with lithium.
        Br J Psychiatry. 1972; 120: 409-414
        • Risch S.
        • et al.
        Interfaces of psychopharmacology and cardiology—Part One.
        J Clin Psychiatry. 1981; 42: 23-34
        • Stokes P.
        • et al.
        Relationship of lithium chloride dose to treatment response in acute mania.
        Arch Gen Psychiatry. 1976; 33: 1080-1084
        • Taylor W.J.
        • et al.
        A Textbook for the Clinical Application of Therapeutic Drug Monitoring. Abbott Laboratories, Diagnostics Division, Irving, Texas1986
        • Thomsen K.
        • et al.
        Renal lithium excretion in man.
        Am J Physiol. 1968; 215: 823-827
        • Walker R.
        • et al.
        Structural and functional effects of long-term lithium therapy.
        Kidney Int. 1982; 21: S13-S19
        • Wilson J.
        • et al.
        Peritoneal dialysis for lithium poisoning.
        Br Med J. 1971; 2: 749-750

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30730-3

      Copyright

      © 1987 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX